David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like ...

Ziopharm Oncology’s ZIOP shares fell 11% on Sep 28, after the company announced restructuring plans to advance the T-cell receptor (“TCR”) program. To advance the restructuring plans, Ziopharm has ...

Thank you for standing by. This is the conference operator. Welcome to the ZIOPHARM Oncology Inc's First Quarter 2021 Earnings Conference Call. As a reminder all participants are in a listen-only mode ...

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and ...

ZIOP earnings call for the period ending September 30, 2019. Image source: The Motley Fool. Ziopharm Oncology Inc(TCRT -3.12%) Q3 2019 Earnings Call Nov 7, 2019, 4:30 p.m. ET ...

In Donald Trump’s latest press conference, the President-elect took a swipe at the healthcare and pharmaceutical space, suggesting that drug companies are getting away with murder, and hinting at some ...

ZIOPHARM Oncology Inc. (ZIOP) could find an ally in its 200-day moving average ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is struggling today, despite a drug data win for the biotech stock. Earlier, ZIOP ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ZIOPHARM Oncology Inc (NASD: ZIOP), where a total of 13,731 contracts have traded so far, ...

) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified ZIOPHARM Oncology as such a stock due to the following factors: ZIOP has an average ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ZIOPHARM Oncology Inc (NASD: ZIOP), where a total volume of 9,180 contracts has ...